COVID-19: a priority for LIH and IBBL

Cet article n’est actuellement qu’en anglais. La version française sera bientôt disponible.

A dedicated webpage on the priority activities for the two institutes is now available on the LIH website

• Biobanque Intégrée du Luxembourg (IBBL)

LIH and IBBL are closely collaborating with all national healthcare providers and the government in order to contain the current COVID-19 pandemic. Jointly with the Health Directorate of the Luxembourg Ministry of Health and key players in the clinical and biomedical research ecosystem, a variety of priority activities have been identified, leveraging on the cross-sectoral expertise of Research Luxembourg in molecular biology, epidemiology, clinical trials and fundamental research.

To follow the latest news and developments from LIH and Research Luxembourg — a joint initiative of the main players in Luxembourg’s public research sector— a COVID-19 webpage has been created on the LIH website. It can be accessed here.